Jill Mortensen, DO
Geriatric Medicine · Millville, NJNPI 1609816511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $562 and has fallen 61.7% since, to $215 in 2025.
Across 95 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$253
- Novo Nordisk$159
- Integrity Implants Inc. Dba Accelus$157
- GSK$148
- AstraZeneca$107
- Pfizer$97
- plus $589 from 19 others
What the payments were for
- Food & beverage$1,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $253 |
| Novo Nordisk | 11 | $159 |
| Integrity Implants Inc. Dba Accelus | 2 | $157 |
| GSK | 11 | $148 |
| AstraZeneca | 8 | $107 |
| Pfizer | 7 | $97 |
| Boston Scientific | 1 | $61 |
| Johnson & Johnson | 5 | $61 |
| Lilly USA, LLC | 4 | $58 |
| Boehringer Ingelheim | 4 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| Exact Sciences | 2 | $44 |
| Mannkind Corporation | 3 | $43 |
| Valeritas, Inc. | 2 | $36 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Astellas Pharma US Inc | 2 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 2 | $16 |
| Insulet Corporation | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Novartis | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FlareHawk$131
How this compares
$1,510 in reported general payments places this provider in the 70th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 107 | $92,544 |
| OzempicSemaglutide | 52 | $62,958 |
| JanuviaSitagliptin Phosphate | 32 | $44,710 |
| Breo ElliptaFluticasone/Vilanterol | 41 | $36,120 |
| TrulicityDulaglutide | 29 | $28,463 |
| Abilify MaintenaAripiprazole | 13 | $26,357 |
| RybelsusSemaglutide | 12 | $23,584 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $22,583 |
| MyrbetriqMirabegron | 35 | $20,655 |
| XareltoRivaroxaban | 19 | $15,596 |
| DepakoteDivalproex Sodium | 15 | $14,539 |
| FarxigaDapagliflozin Propanediol | 11 | $13,474 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $11,214 |
| EntrestoSacubitril/Valsartan | 12 | $10,279 |
| Incruse ElliptaUmeclidinium Bromide | 17 | $8,898 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $97 | $92,544107 claims |
| Novo NordiskOzempic, Rybelsus | $159 | $86,54264 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta, Anoro Ellipta | $148 | $72,869103 claims |
| MerckJanuvia | $15 | $44,71032 claims |
| Lilly USA, LLCTrulicity | $58 | $28,46329 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $107 | $24,68822 claims |
| Astellas Pharma US IncMyrbetriq | $24 | $20,65535 claims |
| Johnson & JohnsonXarelto | $61 | $15,59619 claims |
| NovartisEntresto | $14 | $10,27912 claims |
| Boehringer IngelheimStiolto Respimat | $53 | $6,62313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Millville
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
- Leslie FeiginDenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.